🇺🇸 FDA

Company profile · Sponsor

S.A.

CRSP · NYSE pharma ZUG, EU
Pipeline
14
Drugs
12
Patents
8

Quick answer

S.A. (CRSP) is a pharma company. headquartered in ZUG, EU. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 12 drugs, and 8 patents to this profile..

Company facts

Ticker CRSP
Exchange NYSE
Company type pharma
Headquarters ZUG, EU
SEC CIK 0001674416

Pipeline (14)

Search pipeline →

  1. CTX001

    S.A.

    Beta-Thalassemia

    phase 3 mab active

    3 trials

  2. CTX001

    S.A.

    Sickle Cell Disease

    phase 3 mab active

    2 trials

  3. CTX110

    S.A.

    B-cell Malignancy

    phase 2 mab terminated

    1 trial

  4. CTX112

    S.A.

    Warm Autoimmune Hemolytic Anemia (WAIHA)

    phase 2 mab active

    1 trial

  5. CTX112

    S.A.

    B-cell Lymphoma

    phase 2 mab active

    1 trial

  6. CTX131

    S.A.

    Clear Cell Renal Cell Carcinoma

    phase 2 mab completed

    1 trial

  7. CTX131

    S.A.

    T Cell Lymphoma

    phase 2 mab completed

    1 trial

  8. CTX112

    S.A.

    SLE (Systemic Lupus)

    phase 1 mab active

    1 trial

  9. CTX120

    S.A.

    Multiple Myeloma

    phase 1 mab terminated

    1 trial

  10. CTX130

    S.A.

    Renal Cell Carcinoma

    phase 1 mab terminated

    1 trial

  11. CTX130

    S.A.

    T Cell Lymphoma

    phase 1 mab terminated

    1 trial

  12. CTX310

    S.A.

    Cardiovascular

    phase 1 small molecule active

    1 trial

  13. VCTX210A unit

    S.A.

    Diabetes Mellitus

    phase 1 other completed

    1 trial

  14. VCTX211

    S.A.

    Diabetes Mellitus

    phase 1 other terminated

    1 trial

Drugs (12)

Search drugs →

  1. dimethyl fumarate

    DIMHERITY

    ORAL approved

    L04AX07

  2. duloxetine

    DULOXETINE VIATRIS (PREVIOUSLY DULOXETINE MYLAN)

    N06AX21

  3. eflornithine

    IFINWIL

    L01XX79

  4. eslicarbazepine acetate

    ZEBINIX

    ORAL approved

    N03AF04

  5. human fibrinogen

    TACHOSIL

    B02BC30

  6. ketoconazole

    KETOCONAZOLE AID-SCFM

    TOPICAL approved

    J02AB02

  7. lebrikizumab

    EBGLYSS

    D11AH10

  8. mecasermin

    INCRELEX

    H01AC03

  9. mifamurtide

    MEPACT

    L03AX15

  10. mitotane

    LYSODREN

    ORAL approved

    L01XX23

  11. opicapone

    ONGENTYS

    ORAL approved

    N04

  12. risperidone

    OKEDI

    INTRAMUSCULAR approved

    N05AX08

Patents (8)

Search patents →

  1. US 12427170

    Universal donor cells

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12344655

    Gene-edited natural killer cells

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344656

    Genetically engineered T cells having improved persistence in culture

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12304968

    T-cells expressing anti-LIV1 chimeric antigen receptor

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12263227

    Optimized mRNA encoding CAS9 for use in LNPs

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12247201

    Materials and methods for treatment of autosomal dominant retinitis pigmentosa

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12241087

    Compositions and methods for differentiating stem cells into NK cells

    Expires Mon Feb 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12227763

    Methods and compositions for treating cancer

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is S.A.?

S.A. (CRSP) is a pharma company. headquartered in ZUG, EU. listed on NYSE. NovaPharmaNews links 14 pipeline programs, 12 drugs, and 8 patents to this profile..

What pipeline programs does S.A. sponsor?

We track 14 ClinicalTrials.gov-linked programs for S.A., including CTX001 and 13 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does S.A. company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.